A detailed history of Balentine LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Balentine LLC holds 8,296 shares of ABT stock, worth $1.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,296
Previous 5,583 48.59%
Holding current value
$1.04 Million
Previous $580,000 62.93%
% of portfolio
0.04%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $271,489 - $320,486
2,713 Added 48.59%
8,296 $945,000
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $1.17 Million - $1.31 Million
-11,649 Reduced 67.6%
5,583 $580,000
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $128,357 - $141,765
-1,172 Reduced 6.37%
17,232 $1.96 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $432,190 - $529,036
-4,792 Reduced 20.66%
18,404 $2.03 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $19,583 - $23,497
-205 Reduced 0.88%
23,196 $2.25 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $71,856 - $80,062
-713 Reduced 2.96%
23,401 $2.55 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $590,749 - $695,346
-6,099 Reduced 20.19%
24,114 $2.44 Million
Q4 2022

Jan 31, 2023

BUY
$95.06 - $111.52 $492,981 - $578,342
5,186 Added 20.72%
30,213 $3.32 Million
Q3 2022

Oct 26, 2022

SELL
$96.76 - $112.03 $828,846 - $959,648
-8,566 Reduced 25.5%
25,027 $2.42 Million
Q2 2022

Oct 26, 2022

BUY
$102.07 - $123.37 $931,694 - $1.13 Million
9,128 Added 37.31%
33,593 $3.65 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $3.43 Million - $4.14 Million
33,593 New
33,593 $3.65 Million
Q1 2022

Oct 26, 2022

SELL
$114.02 - $139.04 $1.04 Million - $1.27 Million
-9,128 Reduced 27.17%
24,465 $2.9 Million
Q4 2021

Oct 26, 2022

SELL
$115.53 - $141.46 $1.64 Million - $2.01 Million
-14,186 Reduced 42.23%
19,407 $2.73 Million
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $1.33 Million - $1.62 Million
-11,484 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $375,061 - $414,927
3,215 Added 38.88%
11,484 $1.36 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $4,443 - $5,230
-42 Reduced 0.51%
8,269 $959,000
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $11,210 - $13,207
-103 Reduced 1.22%
8,311 $996,000
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $29,925 - $32,609
285 Added 3.51%
8,414 $921,000
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $514,558 - $624,893
5,615 Added 223.35%
8,129 $885,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $128,714 - $164,738
1,681 Added 201.8%
2,514 $230,000
Q1 2020

May 18, 2020

SELL
$62.82 - $91.86 $59,113 - $86,440
-941 Reduced 53.04%
833 $66,000
Q4 2019

Sep 02, 2020

BUY
$78.51 - $87.4 $82,199 - $91,507
1,047 Added 144.02%
1,774 $154,000
Q3 2019

Nov 15, 2019

SELL
$81.84 - $88.74 $7,283 - $7,897
-89 Reduced 10.91%
727 $61,000
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $20,989 - $24,480
288 Added 54.55%
816 $69,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $32,107 - $38,734
528 New
528 $39,000
Q1 2018

May 16, 2018

SELL
$56.27 - $63.62 $91,720 - $103,700
-1,630 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $78,337 - $87,433
1,630
1,630 $87,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $219B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.